Overview

Casana provides in-home health monitoring through the Heart Seat, a smart toilet seat that records health data when users sit on it. This data is securely uploaded to the Cloud via WiFi, using clinical algorithms for analysis and a bio-identification algorithm to protect user privacy. Unlike competitors, Casana integrates health monitoring seamlessly into daily life, particularly benefiting those with chronic conditions like hypertension. The goal is to reduce healthcare costs by enabling continuous monitoring and early detection of health issues.

Simplify's Take

What believers are saying

• Casana raised $30M in Series B funding to accelerate growth.
• The telehealth market's growth supports demand for Casana's remote monitoring solutions.
• FDA's focus on digital health innovations may expedite Heart Seat's clearance.

What critics are saying

• Potential FDA clearance delays could impact Heart Seat's market entry.
• Reliance on WiFi may limit usability in areas with poor connectivity.
• Intense competition in telehealth could challenge Casana's market share.

What makes Casana unique

• Casana's Heart Seat offers non-invasive, continuous health monitoring from home.
• The device integrates bio-identification algorithms for secure, personalized health data.
• Casana's partnership with Bemis Manufacturing enhances production capabilities.

Help us improve and share your feedback! Did you find this helpful?

YesNo

Funding

Total Funding

$45.2M

Below

Industry Average

Funded Over

5 Rounds

Notable Investors:

General Catalyst

Notable Investors:

General Catalyst

$30,000,000

Series B

Jan 2022

Series B funding is typically for startups that have proven their business model and need more funding to expand rapidly—often by entering new markets or adding more products. Investors are usually venture capital firms that specialize in later-stage investments.

Series B Funding Comparison

Below Average

Industry standards

Ind Avg. $35M

$4M

$30M

$30M

$45M

$65M

$100M

View all funding stages